Published Date: 2018-02-07 09:15:42 AM
Description: Osimert (Osimertinib 80mg tablet) , a novel third generation Tyrosine Kinase Inhibitor, Osimertinib 80 mg tablet, indicated for EGFR-mutated Non-small Cell Lung Cancer (NSCLC), is now available from Everest Pharmaceuticals Limited, Bangladesh in HDPE bottle with 30 tablets in each bottle. And the price is almost 100 (hundred) times cheaper than the originator.
Attach File: